These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25686596)

  • 21. Nanoparticles for transcutaneous vaccination.
    Hansen S; Lehr CM
    Microb Biotechnol; 2012 Mar; 5(2):156-67. PubMed ID: 21854553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of nanocarriers for transdermal vaccine delivery.
    Lawson LB; Freytag LC; Clements JD
    Clin Pharmacol Ther; 2007 Dec; 82(6):641-3. PubMed ID: 17998911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical vaccination: the skin as a unique portal to adaptive immune responses.
    Huang CM
    Semin Immunopathol; 2007 Apr; 29(1):71-80. PubMed ID: 17621956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.
    Bramson J; Dayball K; Evelegh C; Wan YH; Page D; Smith A
    Gene Ther; 2003 Feb; 10(3):251-60. PubMed ID: 12571633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the basis of transcutaneous vaccine delivery.
    Gamazo C; Pastor Y; Larrañeta E; Berzosa M; Irache JM; Donnelly RF
    Ther Deliv; 2019 Jan; 10(1):63-80. PubMed ID: 30730825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro-fractional Epidermal Powder Delivery for Skin Vaccination.
    Jia F; Liu S; Wu MX; Chen X
    Methods Mol Biol; 2016; 1404():715-723. PubMed ID: 27076332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the use of laser technology in skin vaccination.
    Chen X; Wang J; Shah D; Wu MX
    Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA delivery for vaccination and therapeutics through the skin.
    Foldvari M; Babiuk S; Badea I
    Curr Drug Deliv; 2006 Jan; 3(1):17-28. PubMed ID: 16472090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies.
    Karande P; Mitragotri S
    Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
    Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
    Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
    Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.
    Scheiblhofer S; Thalhamer J; Weiss R
    Expert Opin Drug Deliv; 2013 Jun; 10(6):761-73. PubMed ID: 23425032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.
    Ploin D; Schwarzenbach F; Dubray C; Nicolas JF; Goujon C; Trong MD; Laurent PE
    Vaccine; 2011 Oct; 29(46):8438-42. PubMed ID: 21821081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo.
    Crowther JM; Sieg A; Blenkiron P; Marcott C; Matts PJ; Kaczvinsky JR; Rawlings AV
    Br J Dermatol; 2008 Sep; 159(3):567-77. PubMed ID: 18616783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcutaneous immunization using common chemicals.
    Karande P; Arora A; Pham TK; Stevens D; Wojicki A; Mitragotri S
    J Control Release; 2009 Sep; 138(2):134-40. PubMed ID: 19426770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and validation of a skin model for the evaluation of intradermal powder injection devices.
    Deng Y; Winter G; Myschik J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):360-8. PubMed ID: 22484250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.